Jeff Yass’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
Jeff Yass's ABCL Position: Q3 2026 in Review
Jeff Yass reduced its AbCellera Biologics (ABCL) stake by 41% in Q3 2026, selling an estimated $79.6K and leaving 12,193 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #12087.
Jeff Yass first reported a position in ABCL in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.7M in Q3 2021. 155 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- Jeff Yass held 12,193 shares of AbCellera Biologics worth $178K as of Q3 2026.
- Jeff Yass sold 8,387 AbCellera Biologics shares in Q3 2026, an estimated $79.6K.
- AbCellera Biologics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12087 holding.
- Jeff Yass first reported a position in AbCellera Biologics in Q4 2020 and has held it in 23 quarters since.
- Jeff Yass's AbCellera Biologics position peaked at $8.7M in Q3 2021.
- 155 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.